numares announces commercial launch of renalTX-SCORE®
Fast-growing innovative diagnostics company numares AG today announced the commercial launch of its new non-invasive test renalTX-SCORE® for the diagnosis of kidney rejection. It is the first test available worldwide evaluating a metabolic biomarker network rather than single biomarkers or tissue biopsy for the diagnosis of an acute rejection reaction following a kidney transplant. renalTX-SCORERead more about numares announces commercial launch of renalTX-SCORE®[…]